These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 28302690)

  • 1. Contact ignition by single-chain XIIa.
    Meijers JC; Schmaier AH
    Blood; 2017 Mar; 129(11):1411-1412. PubMed ID: 28302690
    [No Abstract]   [Full Text] [Related]  

  • 2. Structural and functional characterization of factor XII.
    Tans G; Rosing J
    Semin Thromb Hemost; 1987 Jan; 13(1):1-14. PubMed ID: 3551074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of surface-mediated activation of bovine Factor XII and prekallikrein.
    Sugo T; Ohno Y; Shimada T; Kato H; Iwanaga S
    Adv Exp Med Biol; 1983; 156():87-107. PubMed ID: 6602465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor XII-mediated contact activation related to poor prognosis in disseminated intravascular coagulation.
    Park HS; Gu J; You HJ; Kim JE; Kim HK
    Thromb Res; 2016 Feb; 138():103-107. PubMed ID: 26706311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zinc ions promote the binding of factor XII/factor XIIA to acidic phospholipids but have no effect on the binding of high-Mr kininogen.
    Schousboe I; Halkier T
    Eur J Biochem; 1991 Apr; 197(2):309-14. PubMed ID: 2026153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial identification of the Zn2+-binding sites in factor XII and its activation derivatives.
    Røjkaer R; Schousboe I
    Eur J Biochem; 1997 Jul; 247(2):491-6. PubMed ID: 9266689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of beta-XIIa (Hageman factor fragment) from human plasma.
    Tankersley DL; Alving BM; Finlayson JS
    Thromb Res; 1982 Feb; 25(4):307-17. PubMed ID: 6978550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitogenic effects of coagulation factor XII and factor XIIa on HepG2 cells.
    Schmeidler-Sapiro KT; Ratnoff OD; Gordon EM
    Proc Natl Acad Sci U S A; 1991 May; 88(10):4382-5. PubMed ID: 1852005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New agents for thromboprotection. A role for factor XII and XIIa inhibition.
    Labberton L; Kenne E; Renné T
    Hamostaseologie; 2015; 35(4):338-50. PubMed ID: 25609114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the effect of serine protease inhibitors on activated contact factors. Application in amidolytic assays for factor XIIa, plasma kallikrein and factor XIa.
    Tans G; Janssen-Claessen T; Rosing J; Griffin JH
    Eur J Biochem; 1987 May; 164(3):637-42. PubMed ID: 3552674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of coronary heart disease and activation of factor XII in middle-aged men.
    Miller GJ; Esnouf MP; Burgess AI; Cooper JA; Mitchell JP
    Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):2103-6. PubMed ID: 9351378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A monoclonal antibody raised against human beta-factor XIIa which also recognizes alpha-factor XIIa but not factor XII or complexes of factor XIIa with C1 esterase inhibitor.
    Esnouf MP; Burgess AI; Dodds AW; Sarphie AF; Miller GJ
    Thromb Haemost; 2000 Jun; 83(6):874-81. PubMed ID: 10896241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of negatively charged activating compounds on inactivation of factor XIIa by Cl inhibitor.
    Pixley RA; Schmaier A; Colman RW
    Arch Biochem Biophys; 1987 Aug; 256(2):490-8. PubMed ID: 3497611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated factor XII levels are dependent on factor XII 46C/T genotypes and factor XII zymogen levels, and are associated with vascular risk factors in patients and healthy subjects.
    Ishii K; Oguchi S; Murata M; Mitsuyoshi Y; Takeshita E; Ito D; Tanahashi N; Fukuuchi Y; Oosumi K; Matsumoto K; Kitajima M; Yamamoto M; Watanabe G; Ikeda Y; Watanabe K
    Blood Coagul Fibrinolysis; 2000 Apr; 11(3):277-84. PubMed ID: 10870808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The purification of activated Hageman factor (activated factor XII).
    RATNOFF OD; DAVIE EW
    Biochemistry; 1962 Nov; 1():967-75. PubMed ID: 13973274
    [No Abstract]   [Full Text] [Related]  

  • 16. Modulation of the human monocyte binding site for monomeric immunoglobulin G by activated Hageman factor.
    Chien P; Pixley RA; Stumpo LG; Colman RW; Schreiber AD
    J Clin Invest; 1988 Nov; 82(5):1554-9. PubMed ID: 3263395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of heparin on the activation of factor XII and the contact system in plasma.
    Pixley RA; Cassello A; De La Cadena RA; Kaufman N; Colman RW
    Thromb Haemost; 1991 Nov; 66(5):540-7. PubMed ID: 1725067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prothrombin--substrate for blood plasma kallikrein and factor XIIa].
    Baskova IP; Tiero A; Krizhevskaia IuV; Iarovaia GA; Mirkamalova EG
    Biull Eksp Biol Med; 1983 Aug; 96(8):13-6. PubMed ID: 6603874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct assay of factor XIIa in plasma with synthetic chromogenic substrates.
    Kluft C; Svendsen L; Los P
    Adv Exp Med Biol; 1983; 156():201-4. PubMed ID: 6190367
    [No Abstract]   [Full Text] [Related]  

  • 20. Interaction of bovine factor XIIa with an inhibitor from bovine plasma.
    Thornton RD; Kirby EP
    Biochim Biophys Acta; 1988 Jan; 964(1):19-27. PubMed ID: 3257142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.